In this study, 102 herpes simplex virus isolates were typed by cell culture selection (chicken embryo cells and guinea pig embryo cells [CE/GPE] (12), indirect hemagglutination (3), mixed agglutination (7), counterimmunoelectrophoresis (9), immunoelectroosmophoresis (8), radioimmunoassay (19), complement-dependent cytotoxicity (16) , and monoclonal antibody analysis (17) has been used to distinguish between the two types of herpes simplex virus (HSV). Other than the monoclonal antibody analysis, all procedures require special adsorption of sera to remove cross-reacting antibodies; thus, high-titer type-specific antisera are not easily obtained. Several non-serological techniques, such as nucleic acid hybridization (4) and DNA restriction endonuclease analysis (10), have also been developed. These methods are time-consuming and expensive and cannot be applied routinely in laboratories. Because of these difficulties, typing HSV type t (HSV-1) and HSV type 2 (HSV-2) is not commonly done in most clinical virology laboratories.
A variety of serological techniques, including microneutralization (20) , immunofluorescentantibody staining (5, 14) , immunoperoxidase staining (2), enzyme-linked immunosorbent assay (12) , indirect hemagglutination (3) , mixed agglutination (7), counterimmunoelectrophoresis (9) , immunoelectroosmophoresis (8) , radioimmunoassay (19) , complement-dependent cytotoxicity (16) , and monoclonal antibody analysis (17) has been used to distinguish between the two types of herpes simplex virus (HSV). Other than the monoclonal antibody analysis, all procedures require special adsorption of sera to remove cross-reacting antibodies; thus, high-titer type-specific antisera are not easily obtained. Several non-serological techniques, such as nucleic acid hybridization (4) and DNA restriction endonuclease analysis (10) , have also been developed. These methods are time-consuming and expensive and cannot be applied routinely in laboratories. Because of these difficulties, typing HSV type t and HSV type 2 (HSV-2) is not commonly done in most clinical virology laboratories.
The use of biological markers for differentiating HSV-1 from HSV-2 has been described previously (15) . Since HSV-1 replicates poorly in chicken embryo (CE) cells and HSV-2 is able to form plaques in CE cells, the two virus types can be easily distinguished. More recently, it was reported that differentiation of HSV-1 from HSV-2 can be made by measuring the sensitivity of the viruses to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) (11 Cell culture preparation. Primary RK cells. GPE cells, and CE cells were prepared by methods previously described (6) . Briefly, RK tissues were obtained from 1-to 2-month-old rabbits, and GPE tissues were taken from guinea pigs pregnant for 30 days. For RK tissues 0.25% trypsin in phosphate-buffered saline (PBS) was used, but only 0.005% trypsin in PBS was used for GPE tissues. Cell pellets were suspended at a 1:250 dilution in Eagle minimal essential medium containing Hanks balanced salt solution and 10% heat- Cell culture selectivity. Virus assays were performed in both CE and GPE cells. Serial 10-fold dilutions of each virus stock were prepared. Samples, 0.1 ml per well, were inoculated into Costar plates containing CE or GPE cell monolayers, at two wells per dilution as previously described (15) . After 1 h of adsorption at 35°C, infected cells were overlaid with 0.5% methylcellulose in minimal essential medium containing Earle balanced salt solution and 10% newborn donor calf serum. After incubation for 72 h at 35°C in a 5% CO2 incubator, monolayers were fixed and stained. Plaques were enumerated. and virus titers were calculated.
BVDU sensitivity assay. BVDU was kindly provided by E. DeClerq (Rega Institute for Medical Research. Leuven, Belgium). The drug was suspended in sterile PBS at a concentration of 500 FLg/ml, dispersed in 1-ml portions, and stored at -70°C. The sensitivity of HSV isolates to BVDU was determined by incorporating 0.7 ,ug of BVDU per ml into the methylcellulose overlay medium described above for GPE cell monolayers (11) . In the presence of the drug a plaque reduction of more than 2 log1( indicated HSV-1, whereas no effect on the plaque-forming ability of virus isolates indicated HSV-2.
Microneutralization (plaque reduction neutralization). Antisera to HSV-1 and HSV-2 were purchased commercially. Serial 2-fold dilutions, 1: 
RESULTS
Comparison of four methods for typing HSV isolates. A total of 52 HSV-1 and 50 HSV-2 isolates from various sources were typed by biological (cell culture selection), biochemical (BVDU sensitivity), immunological (plaque reduction neutralization), and immunochemical (indirect immunofluorescence staining) methods. The results are shown in Table 1 . As the last column shows, the percentages of agreement between typing methods were as follows: (Table 1) .
The agreement between neutralization testing and indirect immunofluorescence testing with commercially prepared antisera was 24% (8/33).
Sensitivity of HSV-1 and HSV-2 to BVDU. The incorporation of BVDU into overlay medium to assay 52 HSV-1 isolates resulted in a plaque reduction of more than 2 log10 (Fig. 1) could be typed by both neutralization and indirect immunofluorescence methods (25 isolates were typeable only by the neutralization test, 9 isolates were typeable only by the indirect immunofluorescence test, and 60 isolates were nontypeable by either test).
DISCUSSION
How to type HSV has been a difficult problem to resolve. Although many investigators have tried to develop more specific serological methods, it has been questioned whether serological techniques can be used for typing HSV-1 and HSV-2 because of the antigenic homogeneity of the two types. Finding differences between the biological markers and BVDU sensitivity of HSV-1 and HSV-2 appears to resolve this problem.
In this study, 102 HSV isolates were typed by cell culture selection and BVDU sensitivity assay. One of the HSV-1 strains was not quite as sensitive to BVDU as the other HSV-1 tested, and two of the HSV-2 strains were slightly more sensitive to BVDU than the other HSV-2 strains tested. These three isolates were obtained in 1976 and 1977 and were passaged at least five times. All new isolates, passaged only one or two times, agreed completely when tested with the CE/GPE and BVDU sensitivity systems (11) . An additional 100 new isolates of HSV have recently been typed by the CE/GPE and BVDU sensitivity systems, and results are in 100% agreement as to HSV types (data not shown). In addition, 100% agreement was obtained when BVDU sensitivity and nucleic acid analysis methods were compared (E. Kern, personal communication). Thus, cell culture selection or BVDU sensitivity assay can be conveniently applied for distinguishing HSV-1 from HSV-2 in case typing difficulties arise when one of the above-mentioned immunological methods is used. These non-immunological methods are simple, reliable, and economical and can be routinely used in most diagnostic virology laboratories.
Because of the close immunological relationship between antigens specified by HSV-1 and HSV-2, type-specific animal sera which are available commercially exhibit considerable cross-reactivity and may vary from lot to lot. Consequently, when quantitative differences between HSV-1 and HSV-2 microneutralization titers are compared, the serological typing of virus isolates is equivocal since these differences in titers are relatively small, often less than fourfold. Mosely et al. (13) examined material from herpetic lesions by direct immunofluorescence with commercially available antisera to HSV-1 and HSV-2. They observed that 37 of 54 (69%) specimens reacted with HSV-1 conjugate and that 46 of 54 (85%) specimens reacted with HSV-2 conjugate, suggesting that the conjugates were not strictly type specific. In the present study, because anti-HSV-2 serum cross-reacted with HSV-1 isolates, none of the HSV-1 isolates could be typed by neutralization and indirect immunofluorescence staining methods. Anti-HSV-1 serum also cross-reacted with most HSV-2 isolates. Therefore, we consider that neutralization and indirect immunofluorescence staining methods cannot be reliably applied for differentiating HSV-1 from HSV-2 when typespecific antisera are used without specific adsorption treatment. Such specific adsorption can be expected to improve results but not as much as the described non-immunological methods.
Monoclonal antibody techniques have been recently developed for typing HSV-1 and HSV-2 (1, 17, 18) . Because of the specificity of monoclonal antibodies and the antigenic complexity of the two HSV types, some monoclonal antibodies may only react with certain HSV isolates when a particular method is used, and other monoclonal antibodies may always cross-react with HSV-1 and HSV-2. Furthermore, some monoclonal antibodies may fail to react with some strains which lack the specific antigenic determinant, resulting in some typeable strains and some nontypeable strains. Therefore, pooled monoclonal antibodies for typing HSV-1 and HSV-2 in clinical laboratories may be necessary, as suggested by Pereira et al. (17) .
